BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 62181)

  • 1. Aldosterone and prolactin.
    Olgaard K; Hagen C; Madsen S; Hummer L
    Lancet; 1976 Oct; 2(7992):959. PubMed ID: 62181
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of effect of prolactin inhibition by alpha-bromoergocriptine (CB 154) on plasma aldosterone in anephric and non-nephrectomized patients on regular haemodialysis.
    Olgaard K; Hagen C; Madsen S; Hummer L
    Acta Endocrinol (Copenh); 1977 Jul; 85(3):587-94. PubMed ID: 194447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the plasma-aldosterone response to frusemide by bromocriptine.
    Edwards CR; Miall PA; Hanker JP; Thorner MO; Al-Dujaili EA; Besser GM
    Lancet; 1975 Nov; 2(7941):903-5. PubMed ID: 53377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin, bromocriptine and dopaminergic neurotransmission.
    Lamberts SW; Birkenhäger JC
    Neth J Med; 1976; 19(3):113-7. PubMed ID: 6921
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Prolactin, bromocriptine, and haemostasis.
    Karmali RA; Horrobin DF
    Br Med J; 1975 Aug; 3(5978):307. PubMed ID: 1148797
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: Growth, prolactin and growth hormone in lambs treated with CB154.
    Brown WB; Driver PM; Jones R; Forbes JM
    J Endocrinol; 1976 Jun; 69(3):47P. PubMed ID: 985847
    [No Abstract]   [Full Text] [Related]  

  • 7. Bromocriptine inhibits prolactin and growth-hormone release by human pituitary tumours in culture.
    Mashiter K; Adams E; Beard M; Holley A
    Lancet; 1977 Jul; 2(8030):197-8. PubMed ID: 69814
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial: Bromocriptine--a changing scene.
    Br Med J; 1975 Dec; 4(5998):667-8. PubMed ID: 1239326
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolactin stimulation tests: different response patterns after bromocriptine, lisuride, and metergoline treatment of puerperal women.
    Bohnet HG; Kato K; De Moll H
    Obstet Gynecol; 1988 Jan; 71(1):53-5. PubMed ID: 3336541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two new dopamine agonists that are long acting in vivo but short acting in vitro.
    Grossman A; Yeo T; Delitala G; Hathway NR; Besser GM
    Clin Endocrinol (Oxf); 1980 Dec; 13(6):595-9. PubMed ID: 7226572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Letter: Inhibition of lactation by an antiprolactin substance, CB 154].
    Morin P; Engelmann P; Coustenoble G; Lebrun ; Gueris D
    Nouv Presse Med; 1975 Nov; 4(39):2811-2. PubMed ID: 1105425
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings: Renal interactions of prolactin and bromocriptine.
    Mahajan KK; Manku MS; Davidson H; James MF; Robinson CJ; Horrobin DF
    J Endocrinol; 1976 Mar; 68(3):14P. PubMed ID: 1255072
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of prolactin and CB154 on electrolyte concentration of amniotic fluid in the rat.
    Kühn ER; Vandoren GE
    IRCS J Med Sci; 1975 May; 3(5):246. PubMed ID: 1165170
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of inhibitors of pituitary prolactin release on testicular cholesterol stores, seminal vesicles weight, fertility, and lactation in mice.
    Bartke A
    Biol Reprod; 1974 Oct; 11(3):319-25. PubMed ID: 4480365
    [No Abstract]   [Full Text] [Related]  

  • 15. [Medicamentous ablactation post partum. Comparative study between bromocryptin (Parlodel) and methallenoestrol (Vallestril) as well as 2 combination variants of both preparations].
    Aljinovic A; Gunti J; Pusterla E
    Gynakol Rundsch; 1976; 16(4):276-80. PubMed ID: 1037395
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: Effects of treatment with ovine prolactin and bromocriptine upon growth and exchangeable calcium in mice.
    Karmali RA; James MF; Horrobin DF; Robinson CJ
    J Endocrinol; 1976 Jun; 69(3):47P-48P. PubMed ID: 950541
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolactin secretion inhibition by a new 8alpha-amino-ergoline, CH 29-171.
    Flückiger E; Briner U; Doepfner W; Kovacs E; Marbach P; Wagner HR
    Experientia; 1978 Oct; 34(10):1330-2. PubMed ID: 570121
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: Effects of prolactin and bromocriptine on the response to Moloney sarcoma virus in mice.
    Karmali RA; Horrobin DF
    J Endocrinol; 1975 Nov; 67(2):57P-58P. PubMed ID: 1206305
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of ergocornine, bromocriptine, D-6-methyl-8-ergolinylacetamide and D-6-propyl-8-ergolinylacetamide on the prolactin secretion in goats. Comparison of potency and duration of effect.
    Krejcí P; Rezábek K; Madej A; Stupnicki R; Ausková M; Bílek J
    Arzneimittelforschung; 1982; 32(4):365-8. PubMed ID: 6896644
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: Effects of bromocriptine and prolactin on thymus growth and thymus uptake of tritiated thymidine in mice of the Swiss and Bar Harbor 129 strains.
    Horrobin DF; Karmali RA
    J Endocrinol; 1975 Nov; 67(2):58P-59P. PubMed ID: 1206306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.